GlassScriptPhysician profile
Vinod K Gupta
NPI 1073569232
$255.31
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $18.75 · 2021: $101 · 2022: $15.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $59.41 | 2019 | |
| Vifor Pharma, INC. | $43.50 | 2021 | |
| Horizon Therapeutics Plc | $38.01 | 2021 | |
| Fresenius USA Marketing, INC. | $35.90 | 2021-2022 | |
| Akebia Therapeutics INC | $33.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.75 | 2020 | |
| Cook Medical LLC | $14.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.